ahlam1399
08-08-2016, 05:11 PM
BRIEF-Alkermes submits supplemental new drug application to FDA
* Alkermes submits supplemental new drug application to FDAfor two month dosing option of Aristada for treatment ofschizophreniahttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=xxKivQ07s1g:75fSlyr3Fik:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=xxKivQ07s1g:75fSlyr3Fik:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=xxKivQ07s1g:75fSlyr3Fik:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=xxKivQ07s1g:75fSlyr3Fik:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=xxKivQ07s1g:75fSlyr3Fik:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/xxKivQ07s1g
* Alkermes submits supplemental new drug application to FDAfor two month dosing option of Aristada for treatment ofschizophreniahttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=xxKivQ07s1g:75fSlyr3Fik:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=xxKivQ07s1g:75fSlyr3Fik:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=xxKivQ07s1g:75fSlyr3Fik:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=xxKivQ07s1g:75fSlyr3Fik:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=xxKivQ07s1g:75fSlyr3Fik:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/xxKivQ07s1g